These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15566645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic comparison between systemic and local chemotherapy by carboplatin in dogs.
    Chen C, Wang W, Zhou H, Huang J, Liu P, Song T, Sun M.
    Reprod Sci; 2009 Nov; 16(11):1097-102. PubMed ID: 19657143
    [Abstract] [Full Text] [Related]

  • 3. Chemoembolization of lung metastases--pharmacokinetic behaviour of carboplatin in a rat model.
    Pohlen U, Rieger H, Meyer BT, Loddenkemper C, Buhr HJ, Heitland P, Koester HD, Schneider P.
    Anticancer Res; 2007 Nov; 27(2):809-15. PubMed ID: 17465206
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic comparison between pelvic transarterial chemoembolization and transcatheter arterial chemotherapy in an animal model.
    Song T, Wang W, Liu P, Chen C.
    Mol Med Rep; 2009 Nov; 2(4):663-7. PubMed ID: 21475883
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K, Gervais A, Aikin A, Egorin M, Balis FM.
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Zuhowski EG, Pluim D, Joseph E, Hamburger DR, Working PK, Colbern G, Tonda ME, Potter DM, Eiseman JL.
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [Abstract] [Full Text] [Related]

  • 9. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y, Fujiwara K, Kigawa J, Itamochi H, Nagao S, Aotani E, Terakawa N, Kohno I, Sankai Gynecology Study Group (SGSG).
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics of carboplatin in a patient under hemodialysis].
    Kurata H, Yoshiya N, Ikarashi H, Kaneko T, Kodama S, Tanaka K, Suzuki K, Yoshizawa H, Cho T, Suzuki E.
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):547-50. PubMed ID: 8129398
    [Abstract] [Full Text] [Related]

  • 12. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
    Sonoda A, Nitta N, Ohta S, Itoh R, Takahashi M, Murata K, Morikawa S, Inubushi T, Miyagawa Y, Takamori M, Oonaka Y.
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
    [Abstract] [Full Text] [Related]

  • 13. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL, Liang LJ, Hu WJ, Shen SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
    [Abstract] [Full Text] [Related]

  • 14. [Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
    Nagai N, Murakami T, Ohama K.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1975-9. PubMed ID: 8085848
    [Abstract] [Full Text] [Related]

  • 15. A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve.
    Ghazal-Aswad S, Calvert AH, Newell DR.
    Cancer Chemother Pharmacol; 1996 Sep; 37(5):429-34. PubMed ID: 8599865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of peritoneal carcinomatosis using carboplatin-loaded hydroxyapatite particles.
    Takeyama H, Mohri N, Mizuno I, Akamo Y, Sawai H, Manabe T, Yotsuyanagi T, Nakamura S.
    Anticancer Res; 2006 Sep; 26(6B):4603-6. PubMed ID: 17201184
    [Abstract] [Full Text] [Related]

  • 18. Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation.
    Suzuki Y, Tanaka K, Neghishi D, Shimizu M, Murayama N, Hashimoto T, Yamazaki H.
    Xenobiotica; 2008 Dec; 38(12):1471-5. PubMed ID: 18949658
    [Abstract] [Full Text] [Related]

  • 19. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
    Xu T, Chen XP, Guo YX, Li D, Lu L, Huan GZ, Zhang WG.
    Zhonghua Wai Ke Za Zhi; 2008 Apr 15; 46(8):606-9. PubMed ID: 18844058
    [Abstract] [Full Text] [Related]

  • 20. [Tissue tolerance to pelvic intraarterial chemoembolization].
    Li J.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jan 15; 28(1):41-3, 61. PubMed ID: 8389277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.